MEDGENICS INC's ticker is MDGN and the CUSIP is 58436Q203. A total of 25 filers reported holding MEDGENICS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $6,028,000 | +12.2% | 1,082,300 | +11.8% | 0.00% | – |
| Q2 2016 | $5,374,000 | +49.4% | 968,409 | +18.5% | 0.00% | – |
| Q1 2016 | $3,597,000 | -21.6% | 817,524 | +7.3% | 0.00% | – |
| Q4 2015 | $4,587,000 | -4.1% | 761,993 | +24.6% | 0.00% | – |
| Q3 2015 | $4,784,000 | +39.0% | 611,766 | +9.0% | 0.00% | – |
| Q2 2015 | $3,441,000 | -15.3% | 561,379 | +11.3% | 0.00% | – |
| Q1 2015 | $4,061,000 | +85.2% | 504,526 | +16.4% | 0.00% | – |
| Q4 2014 | $2,193,000 | +16.5% | 433,307 | +19.4% | 0.00% | – |
| Q3 2014 | $1,883,000 | -31.9% | 362,800 | +1.9% | 0.00% | – |
| Q2 2014 | $2,767,000 | +17.1% | 356,135 | +5.2% | 0.00% | – |
| Q1 2014 | $2,362,000 | +41.5% | 338,439 | +21.5% | 0.00% | – |
| Q4 2013 | $1,669,000 | +25.1% | 278,555 | +62.9% | 0.00% | – |
| Q3 2013 | $1,334,000 | +179.7% | 171,014 | +36.2% | 0.00% | – |
| Q2 2013 | $477,000 | – | 125,584 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,058,400 | $8,277,000 | 4.07% |
| Belmont Global Advisors, Inc. | 155,000 | $1,212,000 | 2.06% |
| Broadfin Capital, LLC | 1,545,306 | $12,084,000 | 0.67% |
| CARL DOMINO INC | 34,134 | $267,000 | 0.21% |
| QVT Financial LP | 267,608 | $2,093,000 | 0.07% |
| WHITE PINE CAPITAL LLC | 20,000 | $156,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 119,000 | $931,000 | 0.02% |
| HYMAN CHARLES D | 13,000 | $102,000 | 0.02% |
| Kavar Capital Partners, LLC | 1,500 | $11,000 | 0.01% |
| Brick & Kyle, Associates | 1,000 | $8,000 | 0.01% |